"Nov. 6, 2012 -- The FDA has approved Pfizer's Xeljanz (tofacitinib), a first-of-its-kind treatment for rheumatoid arthritis.
Xeljanz is approved for use by patients not helped by methotrexate, the usual first treatment for RA. It's a "...
Kineret is contraindicated in patients with known hypersensitivity to E coli-derived proteins, Kineret, or any components of the product [see Hypersensitivity Reactions].This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 11/7/2013
Additional Kineret Information
Kineret - User Reviews
Kineret User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options